Inter-individual variability in the expression of the mutated form of hPS1M146L determined the production of Aβ peptides in the PS1xAPP transgenic mice

Authors

  • Cristina Caballero,

    1. Departmento de Bioquimica, Bromatologia, Toxicología y Medicina Legal, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
    Search for more papers by this author
    • Cristina Caballero and Sebastian Jimenez contributed equally to this article.

  • Sebastian Jimenez,

    1. Departmento de Bioquimica, Bromatologia, Toxicología y Medicina Legal, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
    Search for more papers by this author
    • Cristina Caballero and Sebastian Jimenez contributed equally to this article.

  • Ines Moreno-Gonzalez,

    1. Departmento de Biología Celular y Genetica y Fisiologia, Facultad de Ciencias, Universidad de Malaga, Malaga, Spain
    Search for more papers by this author
  • David Baglietto-Vargas,

    1. Departmento de Biología Celular y Genetica y Fisiologia, Facultad de Ciencias, Universidad de Malaga, Malaga, Spain
    Search for more papers by this author
  • Raquel Sanchez-Varo,

    1. Departmento de Biología Celular y Genetica y Fisiologia, Facultad de Ciencias, Universidad de Malaga, Malaga, Spain
    Search for more papers by this author
  • M. Paz Gavilan,

    1. Departmento de Bioquimica, Bromatologia, Toxicología y Medicina Legal, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
    Search for more papers by this author
  • Blanca Ramos,

    1. Departmento de Bioquimica, Bromatologia, Toxicología y Medicina Legal, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
    Search for more papers by this author
  • Juan Carlos del Rio,

    1. Departmento de Bioquimica, Bromatologia, Toxicología y Medicina Legal, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
    Search for more papers by this author
  • Marisa Vizuete,

    1. Departmento de Bioquimica, Bromatologia, Toxicología y Medicina Legal, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
    Search for more papers by this author
  • Antonia Gutierrez,

    1. Departmento de Biología Celular y Genetica y Fisiologia, Facultad de Ciencias, Universidad de Malaga, Malaga, Spain
    Search for more papers by this author
  • Diego Ruano,

    1. Departmento de Bioquimica, Bromatologia, Toxicología y Medicina Legal, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
    Search for more papers by this author
  • Javier Vitorica

    Corresponding author
    1. Departmento de Bioquimica, Bromatologia, Toxicología y Medicina Legal, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
    • Departmento de Bioquimica, Bromatologia, Toxicología y Medicina Legal, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
    Search for more papers by this author

Abstract

The detection of the early phenotypic modifications of Alzheimer's disease (AD) models is fundamental to understand the progression and identify pharmacologic targets of this pathology. However, a large variability within different models and between age-matched mice from the same model has been observed. This variability could be due to heterogeneity in the Aβ production. Present results showed the existence of a large variability in the Aβ deposition in both hippocampus and cortex in 6-month-old PS1xAPP mice. This variability was not due to the expression of hAPP751SL, however, linear relationship between hPS1M146L mRNA and Aβ production was identified. The Aβ content was related to the incorporation of the hPS1M146L into functional γ-secretase complexes, detected by the presence of the corresponding human or endogenous PS1-CTFs. Animals expressing low amount of hPS1M146L mRNA, displayed low hPS1-CTF incorporation and produced a low amount of Aβ peptides. Conversely, mice with relatively high hPS1 mRNA expression displayed high hPS1-CTF and high Aβ deposition. Furthermore, the Aβ total and Aβ1-42 content was increased dramatically by the expression of hPS1M146L (as compared with transgenic APPsl littermates). Therefore, variations in the expression of transgenic form of hPS1M146L in this model, or even between different models, influenced strongly the incorporation of the mutated PS1 into functional γ-secretase complexes, the production of Aβ peptides and, in consequence, the detrimental effects of Aβ peptides. These data might implicate an “apparent gain-of-function” of the γ-secretase complex by the expression of the mutated PS1M146L. © 2007 Wiley-Liss, Inc.

Ancillary